Synopsis
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Taste Masking
Film Formers & Plasticizers
Thickeners and Stabilizers
Coating Systems & Additives
Direct Compression
Empty Capsules
Topical
Chewable & Orodispersible Aids
Co-Processed Excipients
Emulsifying Agents
Parenteral
Granulation
Solubilizers
Coloring Agents
Disintegrants & Superdisintegrants
Surfactant & Foaming Agents
Rheology Modifiers
Controlled & Modified Release
Soft Gelatin
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
28
PharmaCompass offers a list of Nortriptyline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nortriptyline manufacturer or Nortriptyline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nortriptyline manufacturer or Nortriptyline supplier.
PharmaCompass also assists you with knowing the Nortriptyline API Price utilized in the formulation of products. Nortriptyline API Price is not always fixed or binding as the Nortriptyline Price is obtained through a variety of data sources. The Nortriptyline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride, including repackagers and relabelers. The FDA regulates 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride supplier is an individual or a company that provides 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride active pharmaceutical ingredient (API) or 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride finished formulations upon request. The 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers may include 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride DMFs exist exist since differing nations have different regulations, such as 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride USDMF includes data on 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride Drug Master File in Japan (5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride JDMF) empowers 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride Drug Master File in Korea (5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride. The MFDS reviews the 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride KDMF as part of the drug registration process and uses the information provided in the 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with KDMF on PharmaCompass.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride Certificate of Suitability (COS). The purpose of a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride to their clients by showing that a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP has been issued for it. The manufacturer submits a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP holder for the record. Additionally, the data presented in the 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride DMF.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with CEP (COS) on PharmaCompass.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride written confirmation (5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride WC) is an official document issued by a regulatory agency to a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride manufacturer, verifying that the manufacturing facility of a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride APIs or 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride suppliers with NDC on PharmaCompass.
5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride GMP manufacturer or 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride GMP API supplier for your needs.
A 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CoA (Certificate of Analysis) is a formal document that attests to 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride's compliance with 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride specifications and serves as a tool for batch-level quality control.
5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride EP), 5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride USP).
